Hospitalizations for people with opioid use disorder represent an ideal time to start treatment. Project SHOUT helps hospitals start buprenorphine and methadone services, with coaching from UCSF specialists.
Patients with opioid use disorder are frequently hospitalized with complications from the condition, yet don't receive treatment for their underlying disease. This is a missed opportunity that leaves patients at high risk of future overdose. These hospitalizations are an ideal opportunity to start effective medication treatment for addiction and connect patients to ongoing outpatient services.
Two key treatments for opioid use disorder — buprenorphine and methadone — have been proven to cut overdose rates by two-thirds, lower HIV infections, and reduce criminal behavior. As many as 70% of patients are still in treatment after one year, compared to 6% of patients receiving medication-free treatment. However, when patients being treated with buprenorphine or methadone are hospitalized, these medications are often discontinued, increasing their risk of relapse.
This program — Support for Hospital Opioid Use Treatment (Project SHOUT) — provides clinical leaders with the tools they need to start and maintain patients on buprenorphine or methadone during hospitalizations for any condition, be it medical, surgical, or obstetric. Specialists from the University of California, San Francisco (UCSF) will provide a suite of supports: coaching, toolkits, protocols, monographs for pharmacy and therapeutics committees, webinars, and onsite presentations.
Hannah Snyder, MD
SHOUT Project Lead
Clinical Fellow, Primary Care Addiction Medicine
Division of HIV, ID, and Global Medicine & Dept. of Family and Community Medicine
UCSF at Zuckerberg San Francisco General
Diana Coffa, MD
SHOUT Project Mentor
Director, Family and Community Medicine Residency Program
UCSF at Zuckerberg San Francisco General
SHOUT Project Manager
For more information or to join the coalition, please register here.
SHOUT Webinar 1: The Case for Inpatient Opioid Agonist Therapy (OAT)
Wednesday, November 15, 2017, 12-1 PM (PT)
Opioid addiction and opioid-related death rates are climbing, and our medical system is on the front lines. Effective medications can save lives, but not enough patients have access to them. While thousands of patients with opioid use disorder are hospitalized in California each year, they are rarely started on lifesaving treatment for their addiction. In this webinar, we will examine the efficacy of medications for opioid use disorder, evidence for prescribing these medications in hospital settings, and strategies for implementing prescription programs in your hospital.
- Diana Coffa, MD, associate professor, UCSF primary care addiction medicine fellowship program
SHOUT Webinar 2: Buprenorphine and Methadone Induction
Wednesday, November 29, 2017, 12-1 PM (PT)
Buprenorphine and methadone are safe, effective, and potentially lifesaving treatments for hospitalized patients. This practical webinar will give providers the clinical tools necessary to provide methadone and buprenorphine in inpatient settings for nonpregnant adults. Participants will learn about both the clinical guidelines produced by SHOUT and common clinical scenarios that providers face during treatment with opioid agonist therapy.
- Hannah Snyder, MD, UCSF clinical fellow of primary care addiction medicine
- Michelle Geier, PharmD, psychiatric clinical pharmacist supervisor, San Francisco Department of Public Health
SHOUT Webinar 3: Acute Pain and Perioperative Management in Opioid Use Disorder
Wednesday, December 13, 2017, 12-1 PM (PT)
SHOUT Webinar 4: Buprenorphine and Methadone in Pregnancy
Wednesday, December 20, 2017, 12-1 PM (PT)
SHOUT Webinar 5: Logistics of OAT for the Inpatient Hospital Setting
Wednesday, January 17, 2018, 12-1 PM (PT)
SHOUT Webinar 6: Removing Barriers to Implementation (1)
Wednesday, February 14, 2018, 12-1 PM (PT)
SHOUT Webinar 7: Removing Barriers to Implementation (2)
Wednesday March 21, 2018, 12-1 PM (PT)